Amarin Corporation (AMRN) PT Raised to $51 at H.C. Wainwright; REDUCE-IT Update is a 'Home run'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to Amarin Corporation (AMRN) PT Raised to $51 at H.C. Wainwright; REDUCE-IT Update is a 'Home run'

Amarin (AMRN) Mineral Oil Concerns Not an Oil Spill - Cantor Fitzgerald

November 13, 2018 7:45 AM EST

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $35 price target on Amarin Corporation (NASDAQ: AMRN) saying 'Let's Not Treat Mineral Oil Concerns Like An Oil Spill.'

Chen highlighted:

AMRN disclosed new data in its FAQs and in an 8-K which reinforces our view that mineral oil concerns in the placebo arm are overdone. Therefore, we continue to believe that... More

Amarin Corp. (AMRN) Achieves Topline Primary & Secondary Endpoint Results from REDUCE-IT, Cardiovascular Outcomes Trial for Vascepa (icosapent ethyl)

November 12, 2018 6:11 AM EST

Amarin Corporation plc (NASDAQ: AMRN) announced today the primary results from the Vascepa® (icosapent ethyl) cardiovascular (CV) outcomes trial, REDUCE-IT, following presentation of the late-breaking clinical trial results at the 2018 Scientific Sessions of the American Heart Association (AHA) in Chicago, Illinois. REDUCE-IT primary results confirmed 25% relative risk reduction (RRR) for the topline primary endpoint result with... More